{
    "xml": "<topic id=\"PHP2277\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/olanzapine\" basename=\"olanzapine\" title=\"OLANZAPINE\">\n<title>OLANZAPINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_366\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/olanzapine\">Olanzapine</xref>\n</p>\n<data name=\"vtmid\">108441004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_358387308\" title=\"Antipsychotics (second-generation)\">Antipsychotics (second-generation)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34569\" title=\"ANTIPSYCHOTIC DRUGS\" namespace=\"/drug-classes/antipsychotic-drugs\">ANTIPSYCHOTIC DRUGS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP67957\" outputclass=\"drugAction\" rev=\"1.10\" parent=\"/drugs/olanzapine\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>\n<b>Olanzapine</b> is a dopamine D<sub>1</sub>, D<sub>2</sub>, D<sub>4</sub>, 5-HT<sub>2</sub>, histamine- 1-, and muscarinic-receptor antagonist.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67877\" outputclass=\"indicationsAndDose\" rev=\"1.45\" parent=\"/drugs/olanzapine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Schizophrenia</p>\n<p outputclass=\"therapeuticIndication\">Combination therapy for mania</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg daily, adjusted according to response, usual dose 5&#8211;20&#8239;mg daily, doses greater than 10&#8239;mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Preventing recurrence in bipolar disorder</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg daily, adjusted according to response, usual dose 5&#8211;20&#8239;mg daily, doses greater than 10&#8239;mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Monotherapy for mania</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8239;mg daily, adjusted according to response, usual dose 5&#8211;20&#8239;mg daily, doses greater than 15&#8239;mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Control of agitation and disturbed behaviour in schizophrenia or mania</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8211;10&#8239;mg for 1 dose; usual dose 10&#8239;mg for 1 dose, followed by 5&#8211;10&#8239;mg after 2&#8239;hours if required, maximum 3 injections daily for 3 days; maximum daily combined oral and parenteral dose 20&#8239;mg, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 2.5&#8211;5&#8239;mg, followed by 2.5&#8211;5&#8239;mg after 2&#8239;hours if required, maximum 3 injections daily for 3 days; maximum daily combined oral and parenteral dose 20&#8239;mg, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Dose adjustment may be necessary if smoking started or stopped during treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67986\" outputclass=\"contraindications\" rev=\"1.11\" parent=\"/drugs/olanzapine\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<sectiondiv outputclass=\"additionalContraindications\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intramuscular use</p>\n<p>\n<ph outputclass=\"contraindication\">acute myocardial infarction</ph>; <ph outputclass=\"contraindication\">bradycardia</ph>; <ph outputclass=\"contraindication\">recent heart surgery</ph>; <ph outputclass=\"contraindication\">severe hypotension</ph>; <ph outputclass=\"contraindication\">sick sinus syndrome</ph>; <ph outputclass=\"contraindication\">unstable angina</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68021\" outputclass=\"cautions\" rev=\"1.17\" parent=\"/drugs/olanzapine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Bone-marrow depression</ph>; <ph outputclass=\"caution\">diabetes mellitus (risk of exacerbation or ketoacidosis)</ph>; <ph outputclass=\"caution\">hypereosinophilic disorders</ph>; <ph outputclass=\"caution\">low leucocyte count</ph>; <ph outputclass=\"caution\">low neutrophil count</ph>; <ph outputclass=\"caution\">myeloproliferative disease</ph>; <ph outputclass=\"caution\">paralytic ileus</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use</p>\n<p outputclass=\"title\">CNS and respiratory depression</p>\n<p>Blood pressure, pulse and respiratory rate should be monitored for at least 4 hours after intramuscular injection, particularly in those also receiving a benzodiazepine or another antipsychotic (leave at least one hour between administration of olanzapine intramuscular injection and parenteral benzodiazepines).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67719\" outputclass=\"sideEffects\" rev=\"1.19\" parent=\"/drugs/olanzapine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">hypercholesterolaemia</ph>; <ph outputclass=\"sideEffect\">hypertriglyceridaemia</ph>; <ph outputclass=\"sideEffect\">increased appetite</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">oedema</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">amnesia</ph>; <ph outputclass=\"sideEffect\">bradycardia</ph>; <ph outputclass=\"sideEffect\">epistaxis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hepatitis</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>; <ph outputclass=\"sideEffect\">rhabdomyolysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intramuscular use</p>\n<p>\n<ph outputclass=\"sideEffect\">hypoventilation</ph>; <ph outputclass=\"sideEffect\">sinus pause</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67816\" outputclass=\"pregnancy\" parent=\"/drugs/olanzapine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use only if potential benefit outweighs risk; neonatal lethargy, tremor, and hypertonia reported when used in third trimester.</p>\n<p>Extrapyramidal effects and withdrawal syndrome have been reported occasionally in the neonate when antipsychotic drugs are taken during the third trimester of pregnancy.</p>\n<p>Following maternal use of antipsychotic drugs in the third trimester, neonates should be monitored for symptoms including agitation, hypertonia, hypotonia, tremor, drowsiness, feeding problems, and respiratory distress.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68023\" outputclass=\"breastFeeding\" parent=\"/drugs/olanzapine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;present in milk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67932\" outputclass=\"hepaticImpairment\" parent=\"/drugs/olanzapine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Consider initial dose of 5&#8239;mg daily.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67766\" outputclass=\"renalImpairment\" parent=\"/drugs/olanzapine\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Consider initial dose of 5&#8239;mg daily.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67653\" outputclass=\"monitoringRequirements\" parent=\"/drugs/olanzapine\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Blood lipids and weight should be measured at baseline, at 3 months (weight should be measured at frequent intervals during the first 3 months), and then yearly with antipsychotic drugs. Patients taking olanzapine require more frequent monitoring of these parameters: every 3 months for the first year, then yearly.</p>\n<p>Fasting blood glucose should be measured at baseline, at 4&#8211;6 months, and then yearly. Patients taking olanzapine should have fasting blood glucose tested at baseline, after one months&#8217; treatment, then every 4&#8211;6 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP68041\" outputclass=\"directionsForAdministration\" rev=\"1.7\" parent=\"/drugs/olanzapine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Olanzapine orodispersible tablet may be placed on the tongue and allowed to dissolve, or dispersed in water, orange juice, apple juice, milk, or coffee.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57834\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.13\" parent=\"/drugs/olanzapine\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use</p>\n<p>When prescribing, dispensing, or administering, check that this injection is the correct preparation&#8212;this preparation is usually used in hospital for the rapid control of an <i>acute episode</i> and should <b>not</b> be confused with depot preparations which are usually used in the community or clinics for <i>maintenance</i> treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67809\" outputclass=\"patientAndCarerAdvice\" rev=\"1.20\" parent=\"/drugs/olanzapine\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer orodispersible tablets.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2277-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/olanzapine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74602\" title=\"Tablet\" namespace=\"/drugs/olanzapine/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74619\" title=\"Orodispersible tablet\" namespace=\"/drugs/olanzapine/orodispersible-tablet\">Orodispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74596\" title=\"Oral lyophilisate\" namespace=\"/drugs/olanzapine/oral-lyophilisate\">Oral lyophilisate</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78155\" namespace=\"/treatment-summaries/psychoses-and-related-disorders\" title=\"Psychoses and related disorders\" count=\"11\" rel=\"backlink\">Psychoses and related disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78258\" namespace=\"/treatment-summaries/antidepressant-drugs\" title=\"Antidepressant drugs\" count=\"1\" rel=\"backlink\">Antidepressant drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78531\" namespace=\"/treatment-summaries/parkinsons-disease-and-related-disorders\" title=\"Parkinson&#8217;s disease and related disorders\" count=\"1\" rel=\"backlink\">Parkinson&#8217;s disease and related disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78560\" namespace=\"/treatment-summaries/substance-dependence\" title=\"Substance dependence\" count=\"2\" rel=\"backlink\">Substance dependence</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_366\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/olanzapine\" title=\"Olanzapine\" count=\"1\" rel=\"link\">Olanzapine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34569\" namespace=\"/drug-classes/antipsychotic-drugs\" title=\"ANTIPSYCHOTIC DRUGS\" count=\"1\" rel=\"link\">ANTIPSYCHOTIC DRUGS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74602\" namespace=\"/drugs/olanzapine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74619\" namespace=\"/drugs/olanzapine/orodispersible-tablet\" title=\"Orodispersible tablet\" count=\"1\" rel=\"link\">Orodispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74596\" namespace=\"/drugs/olanzapine/oral-lyophilisate\" title=\"Oral lyophilisate\" count=\"1\" rel=\"link\">Oral lyophilisate</xref>\n</links>\n</topic>",
    "id": "PHP2277",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/olanzapine",
    "basename": "olanzapine",
    "title": "OLANZAPINE",
    "interactants": [
        {
            "id": "bnf_int_366",
            "label": "Olanzapine"
        }
    ],
    "vtmid": "108441004",
    "drugClassification": [
        "Antipsychotics (second-generation)"
    ],
    "inheritsFromClass": [
        "ANTIPSYCHOTIC DRUGS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Olanzapine is a dopamine D1, D2, D4, 5-HT2, histamine- 1-, and muscarinic-receptor antagonist.",
                "html": "<p>\n<b>Olanzapine</b> is a dopamine D<sub>1</sub>, D<sub>2</sub>, D<sub>4</sub>, 5-HT<sub>2</sub>, histamine- 1-, and muscarinic-receptor antagonist.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Schizophrenia",
                        "html": "Schizophrenia"
                    },
                    {
                        "textContent": "Combination therapy for mania",
                        "html": "Combination therapy for mania"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10 mg daily, adjusted according to response, usual dose 5&#8211;20 mg daily, doses greater than 10 mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20 mg per day.",
                        "html": "<p>10&#8239;mg daily, adjusted according to response, usual dose 5&#8211;20&#8239;mg daily, doses greater than 10&#8239;mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Preventing recurrence in bipolar disorder",
                        "html": "Preventing recurrence in bipolar disorder"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10 mg daily, adjusted according to response, usual dose 5&#8211;20 mg daily, doses greater than 10 mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20 mg per day.",
                        "html": "<p>10&#8239;mg daily, adjusted according to response, usual dose 5&#8211;20&#8239;mg daily, doses greater than 10&#8239;mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Monotherapy for mania",
                        "html": "Monotherapy for mania"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "15 mg daily, adjusted according to response, usual dose 5&#8211;20 mg daily, doses greater than 15 mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20 mg per day.",
                        "html": "<p>15&#8239;mg daily, adjusted according to response, usual dose 5&#8211;20&#8239;mg daily, doses greater than 15&#8239;mg daily only after reassessment, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase; maximum 20&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Control of agitation and disturbed behaviour in schizophrenia or mania",
                        "html": "Control of agitation and disturbed behaviour in schizophrenia or mania"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 5&#8211;10 mg for 1 dose; usual dose 10 mg for 1 dose, followed by 5&#8211;10 mg after 2 hours if required, maximum 3 injections daily for 3 days; maximum daily combined oral and parenteral dose 20 mg, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase.",
                        "html": "<p>Initially 5&#8211;10&#8239;mg for 1 dose; usual dose 10&#8239;mg for 1 dose, followed by 5&#8211;10&#8239;mg after 2&#8239;hours if required, maximum 3 injections daily for 3 days; maximum daily combined oral and parenteral dose 20&#8239;mg, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase.</p>"
                    },
                    {
                        "textContent": "Initially 2.5&#8211;5 mg, followed by 2.5&#8211;5 mg after 2 hours if required, maximum 3 injections daily for 3 days; maximum daily combined oral and parenteral dose 20 mg, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase.",
                        "html": "<p>Initially 2.5&#8211;5&#8239;mg, followed by 2.5&#8211;5&#8239;mg after 2&#8239;hours if required, maximum 3 injections daily for 3 days; maximum daily combined oral and parenteral dose 20&#8239;mg, when one or more factors present that might result in slower metabolism (e.g. female gender, elderly, non-smoker) consider lower initial dose and more gradual dose increase.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Dose adjustment may be necessary if smoking started or stopped during treatment.",
                "html": "<p>Dose adjustment may be necessary if smoking started or stopped during treatment.</p>"
            }
        ]
    },
    "contraindications": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "acute myocardial infarction",
                "html": "acute myocardial infarction",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "bradycardia",
                "html": "bradycardia",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "recent heart surgery",
                "html": "recent heart surgery",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "severe hypotension",
                "html": "severe hypotension",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "sick sinus syndrome",
                "html": "sick sinus syndrome",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "unstable angina",
                "html": "unstable angina",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Bone-marrow depression",
                "html": "Bone-marrow depression"
            },
            {
                "type": "cautions",
                "textContent": "diabetes mellitus (risk of exacerbation or ketoacidosis)",
                "html": "diabetes mellitus (risk of exacerbation or ketoacidosis)"
            },
            {
                "type": "cautions",
                "textContent": "hypereosinophilic disorders",
                "html": "hypereosinophilic disorders"
            },
            {
                "type": "cautions",
                "textContent": "low leucocyte count",
                "html": "low leucocyte count"
            },
            {
                "type": "cautions",
                "textContent": "low neutrophil count",
                "html": "low neutrophil count"
            },
            {
                "type": "cautions",
                "textContent": "myeloproliferative disease",
                "html": "myeloproliferative disease"
            },
            {
                "type": "cautions",
                "textContent": "paralytic ileus",
                "html": "paralytic ileus"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use",
                    "routes": [
                        "intramuscular"
                    ]
                },
                "title": "CNS and respiratory depression",
                "textContent": "Blood pressure, pulse and respiratory rate should be monitored for at least 4 hours after intramuscular injection, particularly in those also receiving a benzodiazepine or another antipsychotic (leave at least one hour between administration of olanzapine intramuscular injection and parenteral benzodiazepines).",
                "html": "<p>Blood pressure, pulse and respiratory rate should be monitored for at least 4 hours after intramuscular injection, particularly in those also receiving a benzodiazepine or another antipsychotic (leave at least one hour between administration of olanzapine intramuscular injection and parenteral benzodiazepines).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypercholesterolaemia",
                        "html": "hypercholesterolaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypertriglyceridaemia",
                        "html": "hypertriglyceridaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "increased appetite",
                        "html": "increased appetite",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "amnesia",
                        "html": "amnesia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "bradycardia",
                        "html": "bradycardia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Hepatitis",
                        "html": "Hepatitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "rhabdomyolysis",
                        "html": "rhabdomyolysis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypoventilation",
                        "html": "hypoventilation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "sinus pause",
                        "html": "sinus pause",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use only if potential benefit outweighs risk; neonatal lethargy, tremor, and hypertonia reported when used in third trimester.\n\nExtrapyramidal effects and withdrawal syndrome have been reported occasionally in the neonate when antipsychotic drugs are taken during the third trimester of pregnancy.\n\nFollowing maternal use of antipsychotic drugs in the third trimester, neonates should be monitored for symptoms including agitation, hypertonia, hypotonia, tremor, drowsiness, feeding problems, and respiratory distress.",
                "html": "<p>Use only if potential benefit outweighs risk; neonatal lethargy, tremor, and hypertonia reported when used in third trimester.</p><p>Extrapyramidal effects and withdrawal syndrome have been reported occasionally in the neonate when antipsychotic drugs are taken during the third trimester of pregnancy.</p><p>Following maternal use of antipsychotic drugs in the third trimester, neonates should be monitored for symptoms including agitation, hypertonia, hypotonia, tremor, drowsiness, feeding problems, and respiratory distress.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;present in milk.",
                "html": "<p>Avoid&#8212;present in milk.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Consider initial dose of 5 mg daily.",
                "html": "<p>Consider initial dose of 5&#8239;mg daily.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Consider initial dose of 5 mg daily.",
                "html": "<p>Consider initial dose of 5&#8239;mg daily.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Blood lipids and weight should be measured at baseline, at 3 months (weight should be measured at frequent intervals during the first 3 months), and then yearly with antipsychotic drugs. Patients taking olanzapine require more frequent monitoring of these parameters: every 3 months for the first year, then yearly.\n\nFasting blood glucose should be measured at baseline, at 4&#8211;6 months, and then yearly. Patients taking olanzapine should have fasting blood glucose tested at baseline, after one months&#8217; treatment, then every 4&#8211;6 months.",
                "html": "<p>Blood lipids and weight should be measured at baseline, at 3 months (weight should be measured at frequent intervals during the first 3 months), and then yearly with antipsychotic drugs. Patients taking olanzapine require more frequent monitoring of these parameters: every 3 months for the first year, then yearly.</p><p>Fasting blood glucose should be measured at baseline, at 4&#8211;6 months, and then yearly. Patients taking olanzapine should have fasting blood glucose tested at baseline, after one months&#8217; treatment, then every 4&#8211;6 months.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Olanzapine orodispersible tablet may be placed on the tongue and allowed to dissolve, or dispersed in water, orange juice, apple juice, milk, or coffee.",
                "html": "<p>Olanzapine orodispersible tablet may be placed on the tongue and allowed to dissolve, or dispersed in water, orange juice, apple juice, milk, or coffee.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use",
                    "routes": [
                        "intramuscular"
                    ]
                },
                "textContent": "When prescribing, dispensing, or administering, check that this injection is the correct preparation&#8212;this preparation is usually used in hospital for the rapid control of an acute episode and should not be confused with depot preparations which are usually used in the community or clinics for maintenance treatment.",
                "html": "<p>When prescribing, dispensing, or administering, check that this injection is the correct preparation&#8212;this preparation is usually used in hospital for the rapid control of an <i>acute episode</i> and should <b>not</b> be confused with depot preparations which are usually used in the community or clinics for <i>maintenance</i> treatment.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer orodispersible tablets.",
                "html": "<p>Patients or carers should be given advice on how to administer orodispersible tablets.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74602",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74619",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74596",
                "label": "Oral lyophilisate",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78155",
                "label": "Psychoses and related disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78258",
                "label": "Antidepressant drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78531",
                "label": "Parkinson&#8217;s disease and related disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78560",
                "label": "Substance dependence",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_366",
                "label": "Olanzapine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34569",
                "label": "ANTIPSYCHOTIC DRUGS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74602",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74619",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74596",
                "label": "Oral lyophilisate",
                "type": "medicinalForm"
            }
        ]
    }
}